(Q84616364)
Statements
Telomere shortening, clonal evolution and disease progression in myelodysplastic syndrome patients with 5q deletion treated with lenalidomide (English)
G Göhring
K Lange
W Hofmann
K V Nielsen
E Hellström-Lindberg
L Roy
M Morgan
H Kreipe
G Büsche
A Giagounidis
B Schlegelberger